Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

December 01, 2006 (Vol. 26, No. 21)

Gauging Nanobiotech's Promise Realistically

Biotech and Pharma Firms Are Taking a Wait-and-See Approach

  • Biotech products based on nanotechnology are becoming more widespread, but not without first encountering substantial challenges. According to a report issued by the ETC Group (www.etcgroup.org/en), the major pharmaceutical companies generally have been taking a wait-and-see attitude on nanotechnology. According to the report, and confirmed by a number ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.